🟢 Kailera Therapeutics is trading 6.06% up in pre-market possibly ahead of August 12 earnings

Kailera Therapeutics is trading 6.06% up at $19.79 in pre-market, with positioning ahead of its August 12 second-quarter 2026 earnings a possible factor.

• The investor-relations calendar lists earnings for August 12; no new company-specific announcement was identified for August 10, 2026.
• The broader market is slightly weaker, so index momentum does not appear to explain the gain.
• Earlier July clinical-trial news remains stale and is not a clear catalyst.